TECH vs WLYB · P/E 65, rev $1.22B vs P/E 15, rev $1.68B
Bio-Techne Corp (TECH) versus John Wiley & Sons B (WLYB) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
John Wiley & Sons B (WLYB) is a publishing company listed on NYSE.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported WLYB revenue for 2025-04-30 was $1.68B. Net income was $84.2M. Revenue was down 10.4% from 2024-04-30 to 2025-04-30. WLYB currently screens at market cap $2.26B and trailing P/E 15.4.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. WLYB currently screens at market cap $2.26B and trailing P/E 15.4.
Not investment advice. Open the TECH and WLYB stock pages for the full models.
Not investment advice.